Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

The Secrets of Efficient Combination Product Development

When developing combination products, the local legal requirements are highly variable.

In the US, the Food and Drug Administration (FDA) has laid out requirements for the development and manufacture of combination products in CFR Part 4. In addition to good manufacturing practices (GMP) requirements for medicinal products (12 CFR 210/211), relevent controls (certain sections of 21 CFR 820) for the product and development of medical devices also need to be fulfilled.

In the EU, these products are registered as medicinal products. The applicability of Medical Device Regulation (MDR) is limited to requirements on safety and performance of the device (Annex of the MDR).

In Canada, Australia and Japan, combination products are mentioned in the local regulations, regulated as either drug or device depending on the primary mode of action (PMOA).

Download this free white paper to find out more.

The Secrets of Efficient Combination Product Development

For Free, instant access, click below.

Download Whitepaper

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.

Thank You

Your white paper is now downloading... Click here if the download does not begin.

Go Top